-- Earnings Flash (ATHX) ATHERSYS Posts Q1 Revenue $2.9M, vs. Street Est of $1.38M
8:03AM ET 5/06/2022 MT Newswires...
...
Athersys (ATHX) on Thursday filed a shelf registration statement for the potential sale of up to $250 million of its securities from time to time. The...
Myovant (MYOV) shares slumped 21% after the US Food and Drug Administration flagged certain deficiencies in the company's supplemental new drug application...
Curis (CRIS) shares slumped 32% after the company said the US Food and Drug Administration placed the company's leukemia drug on partial clinical hold....
Address | 3201 Carnegie Avenue Cleveland, Ohio 44115-2634 |
Phone | +1.216.431.9900 |
Number of Employees | 75 |
Recent SEC Filing | 05/12/2022![]() |
Chief Executive Officer & Director | Daniel A. Camardo |
President & Chief Operating Officer | William B. J. Lehmann |
Chief Financial & Accounting Officer | Ivor MacLeod |
Director, Chief Scientific Officer & Executive VP | John J. Harrington |
Price Open | $0.72 |
Previous Close | $0.71 |
52 Week Range | $0.46 - 1.81 |
Market Capitalization | $179.4 M |
Shares Outstanding | 252.0 M |
Sector | Health Technology |
Industry | Biotechnology | Next Earnings Announcement | 08/08/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$0.35 |
Beta vs. S&P 500 | N/A |
Revenue | $24.3 M |
Net Profit Margin | -981.52% |
Return on Equity | -429.24% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |